Advertisement
Review Article| Volume 32, ISSUE 3, P739-747, September 2005

Download started.

Ok

Tuberculosis in Pregnancy

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Frieden T.R.
        • Sterling T.R.
        • Munsiff S.S.
        • et al.
        Tuberculosis.
        Lancet. 2003; 362: 887-899
        • Starke J.R.
        Tuberculosis.
        Clin Perinatol. 1997; 24: 107-127
        • Medchill M.T.
        • Gillum M.
        Diagnosis and management of tuberculosis during pregnancy.
        Obstet Gynecol Surv. 1989; 44: 81-84
        • Miller K.S.
        • Miller Jr, J.M.
        Tuberculosis in pregnancy: interactions, diagnosis, and management.
        Clin Obstet Gynecol. 1996; 39: 120-142
        • Weinberger S.E.
        • Weiss S.T.
        • Cohen W.R.
        • et al.
        Pregnancy and the lung.
        Am Rev Respir Dis. 1980; 121: 559-581
        • Schluger N.W.
        • Rom W.N.
        The host immune response to tuberculosis.
        Am J Respir Crit Care Med. 1998; 157: 679-691
        • Sodhi A.
        • Gong J.
        • Silva C.
        • et al.
        Clinical correlates of interferon-gamma production in patients with tuberculosis.
        Clin Infect Dis. 1997; 25: 617-620
        • Braunwald E.
        • Fauci A.S.
        • Kasper D.L.
        • et al.
        Harrison's principles of internal medicine. 16th edition. McGraw-Hill, New York2005
        • Markowitz N.
        • Hansen N.I.
        • Hopewell P.C.
        • et al.
        Incidence of tuberculosis in the United States among HIV-infected persons.
        Ann Intern Med. 1997; 126: 123-132
        • Westerholm P.
        • Ahlmark A.
        • Maasing R.
        • et al.
        Silicosis and risk of lung cancer or lung tuberculosis: a cohort study.
        Environ Res. 1986; 41: 339-350
        • Lundin A.P.
        • Adler A.J.
        • Berlyne G.M.
        • et al.
        Tuberculosis in patients undergoing maintenance hemodialysis.
        Am J Med. 1979; 67: 597-602
        • Andrew O.T.
        • Schoenfeld P.Y.
        • Hopewell P.C.
        • et al.
        Tuberculosis in patients with end-stage renal disease.
        Am J Med. 1980; 68: 59-65
        • Boucot K.R.
        • Dillon E.S.
        • Cooper D.A.
        • et al.
        Tuberculosis among diabetics: the Philadelphia Survey.
        Am Rev Tuberc. 1952; 65: 1-50
        • Wilson E.A.
        • Thelin T.J.
        • Dilts P.V.
        Tuberculosis complicated by pregnancy.
        Am J Obstet Gynecol. 1972; 115: 526-529
        • Sahn S.
        • Neff T.
        Miliary tuberculosis.
        Am J Med. 1974; 56: 495-505
        • Grieco M.H.
        • Chmel H.
        Acute disseminated tuberculosis as a diagnostic problem.
        Am Rev Respir Dis. 1974; 109: 554-560
        • Menitove S.
        • Harris H.W.
        Miliary tuberculosis.
        in: Schlossberg D. Tuberculosis. 2nd edition. Springer-Verlag, New York1988: 179-189
        • Cooper A.R.
        • Heneghan W.
        • Matthew J.D.
        Tuberculosis in a mother and her infant.
        Pediatr Infect Dis. 1985; 4: 181-183
        • Beitzke H.
        Ueber die angeborene tuberkuloese infection [About the congenital tuberculosis infection].
        Ergeb Gesamten Tuberkuloseforsch. 1935; 7: 1-30
        • Vallejo J.G.
        • Starke J.R.
        Tuberculosis in pregnancy.
        Clin Chest Med. 1992; 13: 693-707
        • Hertzog A.J.
        • Chapman S.
        • Herring J.
        Congenital pulmonary aspiration-tuberculosis.
        Am J Clin Pathol. 1940; 19: 1139-1142
        • Cantwell M.F.
        • Shehab Z.M.
        • Costello A.M.
        • et al.
        Brief report: congenital tuberculosis.
        N Engl J Med. 1994; 330: 1051-1054
        • Hageman J.
        • Shulman S.
        • Schreiber M.
        • et al.
        Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures.
        Pediatrics. 1980; 66: 980-984
        • Huebner R.E.
        • Schein W.
        • Bass Jr, J.B.
        The tuberculin skin test.
        Clin Infect Dis. 1993; 17: 968-975
        • Centers for Disease Control and Prevention
        Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.
        MMWR Recomm Rep. 2000; 49: 1-51
        • Sepulveda R.L.
        • Ferrer X.
        • Latrach C.
        • et al.
        The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults.
        Am Rev Respir Dis. 1990; 142: 24-28
        • American Thoracic Society
        Diagnostic standards and classification of tuberculosis in adults and children.
        Am J Respir Crit Care Med. 2000; 161: 1376-1395
        • Franks A.L.
        • Binkin N.J.
        • Snider Jr, D.E.
        • et al.
        Isoniazid hepatitis among pregnant and postpartum Hispanic patients.
        Public Health Rep. 1989; 104: 151-155
        • Snider Jr, D.E.
        • Caras G.J.
        Isoniazid-associated hepatitis deaths: a review of available information.
        Am Rev Respir Dis. 1992; 145: 494-497
      1. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation. 5th edition. Baltimore (MD): Williams & Wilkins; 1998. p. 400–1, 562–4, 918–9, 945–6

        • Snider D.E.
        • Powell K.E.
        Should women taking antituberculosis drugs breast-feed?.
        Arch Intern Med. 1984; 144: 589-590
        • American Thoracic Society
        • Centers for Disease Control and Prevention
        • and Infectious Diseases Society of America
        Treatment of tuberculosis.
        MMWR Morb Mortal Wkly Rep. 2003; 52: 1-77
        • Snider D.E.
        Pyridoxine supplementation during isoniazid therapy.
        Tubercle. 1980; 61: 191-196
        • Ludford J.
        • Doster B.
        • Woolpert S.F.
        Effect of isoniazid on reproduction.
        Am Rev Respir Dis. 1973; 108: 1170-1174
        • Dickinson J.M.
        • Mitchison D.A.
        Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.
        Am Rev Respir Dis. 1981; 123: 367-371
        • Steen J.S.
        • Stainton-Ellis D.M.
        Rifampicin in pregnancy.
        Lancet. 1977; ii: 604-605
        • Girling D.J.
        The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis.
        Tubercle. 1984; 65: 1-4
        • Døssing M.
        • Wilcke J.T.R.
        • Askgaard D.S.
        • et al.
        Liver injury during antituberculosis treatment: an 11-year study.
        Tuber Lung Dis. 1996; 77: 335-340
        • World Health Organization
        Treatment of tuberculosis: guidelines for national programmes. 2nd edition. World Health Organization, Geneva ( Switzerland)1997
        • Enarson D.A.
        • Rieder H.L.
        • Arnodottir T.
        • et al.
        Tuberculosis guide for low income countries. 4th edition. International Union against Tuberculosis and Lung Diseases, Paris1996
        • Davidson P.T.
        Managing tuberculosis during pregnancy.
        Lancet. 1995; 346: 199-200
        • Bobrowitz I.D.
        Ethambutol in pregnancy.
        Chest. 1974; 66: 20-24
        • Lewit T.
        • Nebel L.
        • Terracina S.
        • et al.
        Ethambutol in pregnancy: observations on embryogenesis.
        Chest. 1974; 66: 25-26
        • Snider D.E.
        • Layde P.M.
        • Johnson M.W.
        • et al.
        Treatment of tuberculosis during pregnancy.
        Am Rev Respir Dis. 1980; 122: 65-79
        • Doster B.
        • Murray F.J.
        • Newman R.
        • et al.
        Ethambutol in the initial treatment of pulmonary tuberculosis.
        Am Rev Respir Dis. 1973; 107: 177-190
        • Tugwell P.
        • James S.L.
        Peripheral neuropathy with ethambutol.
        Postgrad Med J. 1972; 48: 667-670
        • United States Pharmacopeial Dispensing Information
        Drug information for the health care professional, vol. I. Micromedex, Englewood (CO)1999
        • Conway N.
        • Birt B.D.
        Streptomycin in pregnancy: effect on the foetal ear.
        BMJ. 1965; 2: 260-263
        • Robinson G.C.
        • Cambon K.G.
        Hearing loss in infants of tuberculous mothers treated with streptomycin during pregnancy.
        N Engl J Med. 1964; 271: 949-951
        • Peloquin C.A.
        Antituberculosis drugs: pharmacokinetics.
        in: Heifets L.B. Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton (FL)1991: 59-88
        • Lipsky B.A.
        • Baker C.A.
        Fluoroquinolone toxicity profiles: a review focusing on newer agents.
        Clin Infect Dis. 1999; 28: 352-364
        • Jindani A.
        • Aber V.R.
        • Edwards E.A.
        • et al.
        The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
        Am Rev Respir Dis. 1980; 121: 939-949
        • Chan S.L.
        • Yew W.W.
        • Ma W.K.
        • et al.
        The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
        Tuber Lung Dis. 1992; 73: 33-38
        • Sirgel F.A.
        • Botha F.J.H.
        • Parkin D.P.
        • et al.
        The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment.
        J Antimicrob Chemother. 1993; 32: 867-875
        • Hafner R.
        • Cohn J.A.
        • Wright D.J.
        • et al.
        Early bactericidal activity of isoniazid in pulmonary tuberculosis.
        Am J Respir Crit Care Med. 1997; 156: 918-923
        • East Africa/British Medical Research Council
        Controlled clinical trial of five short-course (4 month) chemotherapy regimens in pulmonary tuberculosis: second report of the 4th study.
        Am Rev Respir Dis. 1981; 123: 165-170
        • Singapore Tuberculosis Service/British Medical Research Council
        Long-term follow-up of a clinical trial of 6-month and 4-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
        Am Rev Respir Dis. 1986; 133: 779-783